BCM
EOLS icon

Bayesian Capital Management’s Evolus EOLS Stock Holding History

Bayesian Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,034
Closed -$72.9K – 782
2023
Q2 		$72.9K Buy
+10,034
New +$86.6K 0.01% 710

Other funds holding EOLS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bayesian Capital Management's EOLS Position: Q3 2023 in Review

Bayesian Capital Management sold out of Evolus (EOLS) in Q3 2023, closing a stake of 10,034 shares — an estimated $72.9K sold.

Bayesian Capital Management first reported a position in EOLS in Q2 2023 and held it in 1 quarter. The position peaked at $72.9K in Q2 2023. 137 funds tracked by Wall St. Rank hold EOLS as of Q3 2023.

  • Bayesian Capital Management reported no remaining Evolus position as of Q3 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 10,034 Evolus shares in Q3 2023, an estimated $72.9K.
  • Bayesian Capital Management first reported a position in Evolus in Q2 2023 and held it in 1 quarter.
  • Bayesian Capital Management's Evolus position peaked at $72.9K in Q2 2023.
  • 137 funds tracked by Wall St. Rank held Evolus as of Q3 2023.

Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.